Drugs & Targets FDA grants Priority Review for Keytruda + chemotherapy as first-line for squamous NSCLC July 06, 2018Vol.44 No.27
Drugs & Targets Lynparza approved in Japan for BRCA-mutated metastatic breast cancer July 06, 2018Vol.44 No.27
Clinical Roundup Tecentriq + Abraxane reduced risk of disease worsening, death in triple negative breast cancer July 06, 2018Vol.44 No.27
Clinical Roundup NewLink reports updated phase I data for indoximod + chemotherapy to treat DIPG July 06, 2018Vol.44 No.27
Funding Opportunities DOD Peer Reviewed Cancer Research Program opportunities July 06, 2018Vol.44 No.27
BSA approves 10 NCI concepts, including six Moonshot RFAs July 06, 2018Vol.44 No.27By Jordan Williams
Conversation with The Cancer Letter How the Rabson “practice” helped more than 14,000 patients in 55 years July 06, 2018Vol.44 No.27By Paul Goldberg
